Business Wire

NEP-GROUP

Share
NEP Appoints Lise Heidal as President, NEP Broadcast Services Europe

NEP Group, the leading worldwide media technology partner for live sports and entertainment, announced today that Lise Heidal has been appointed President, NEP Europe for NEP Broadcast Services, effective 1 April. Based in Norway, Heidal will set the strategy, priorities and focus areas for nine countries in Northern, Central and Southern Europe, as well as in the UK and Ireland, to lead the future planning of NEP’s broadcast services businesses.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240216806377/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Industry veteran Lise Heidal has been appointed President, NEP Europe for NEP Broadcast Services. She will set the strategy, priorities and focus areas for all countries in Northern, Central and Southern Europe, as well as in the UK and Ireland, to lead the future planning of NEP’s broadcast services businesses. (Photo: Business Wire)

With over 25 years of multifaceted experience in the media, telecom, and consulting industries, Heidal stands out as a pragmatic leader committed to driving operational excellence, business transformation and strategic innovation. Known as someone committed to building great teams with a genuine interest in the people she works with, Heidal’s approach combines strategic vision and operational expertise, whilst fostering a culture of accountability. Most recently she served 2,5 years as the VP of Production at TV 2, the largest commercial broadcaster in Norway. Prior to that, she served as Managing Director of NEP Norway and led several global NEP initiatives that achieved continuous development and profitable growth from 2010 to 2021.

As part of the new European leadership team, Christer Pålsson has been named Chief Commercial Officer for Europe, reporting into Heidal. As CCO, Pålsson will be responsible for all commercial and sales activities across the region and work closely with NEP’s global sales team to align strategy and execution, including for major events worldwide. He brings with him extensive experience in business leadership, sales, client service, partnerships and operations for NEP in the Nordics, Central and Southern Europe. Prior to joining NEP, Pålsson was Head of International Sales for Mediatec Broadcasting company, which became a part of NEP in 2015.

To support this transition NEP is also pleased to announce that Jose (Tex) Teixeira will join NEP on 4 April initially as President for NEP Nordics, Central & Southern Europe. Teixeira brings with him over 30 years of sport broadcast experience delivering world-class live productions in Africa and New Zealand. A creative, loyal and energetic individual with a can-do spirit, he has specialised in content strategy and acquisition, programming and production, leading large teams, building dynamic environments and managing strategic relationships with rights holders, federations and suppliers across multiple territories throughout his career. He most recently served as Chief Content Officer for SuperSport and as their Interim CEO in 2023.

Rounding out the European senior leadership team, Arjan van Westerloo and Steve Jenkins will continue in their current roles as President, NEP The Netherlands, and President, NEP UK & Ireland, respectively.

Mike Werteen, Global President of NEP Broadcast Services, said: “Combining our UK and European businesses under a single, dynamic and experienced leadership team is an exciting step forward. Having such a powerful group in place enables us to achieve our vision to be the leading global media services provider in live sports and entertainment. Under Lise’s direction, supported by the foundations that all European and UK team members have put into place, I’m confident we will be able to harness all of the talent, synergies, sales and employee career opportunities across these important markets.”

Lise Heidal said: "I am deeply honored to accept the position as lead of the NEP Broadcast Services European organization. It is a privilege to have the opportunity to work with a team of such dedicated and talented individuals. I am fully committed to enhancing our collaborative efforts across Europe, to serving our clients, and to continue building on our shared successes."

While continuing to manage the day-to-day business, the first priority for the European leadership team will be to drive increased collaboration and process improvements for the region as part of the company’s 2024 goals and longer-term plans.

For more information about NEP, visit www.nepgroup.com.

About NEP

You have a vision. We see it, too. With a worldwide network of experts and cutting-edge technology, our unique Global Production Ecosystem empowers content creators and rights holders to tell stories in breakthrough ways. We're built on 35 years of trusted experience across broadcast, live event, and virtual production to deliver the solutions you need—anytime, anywhere.

Headquartered in the United States, NEP has operations in 25 countries with over 5,000 employees. Together, we have supported productions in over 100 countries on all seven continents, and we’re still growing. Learn how we help our clients bring content to life at nepgroup.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240216806377/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press release

First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER studyIn MANEUVER, pimicotinib significantly improved objective response rate at week 25 (54% vs. 3.2% for placebo), while providing clinically meaningful and statistically significant improvements across all patient-reported outcomesWith longer-term follow-up, 3 out of 4 patients treated with pimicotinib achieved response per RECIST v1.1, and treatment continued to be well-toleratedApproval strengthens Merck’s leadership in rare tumors, with additional ongoing regulatory filings for pimicotinib underway globally Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity.

Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press release

Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi

Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer22.12.2025 08:42:00 CET | Press release

Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of advanced squamous cell carcinoma of the anal canal (SCAC). "Today's approval marks a significant milestone for patients with advanced anal cancer in Japan – the MHLW’s approval of Zynyz as the first and only first-line treatment for SCAC," said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan G.K. "By offering combination therapy with chemotherapy, Zynyz provides a vital new path forward for patients facing this challenging disease, addressing a significant unmet need in cancer care for patients with SCAC and their families." The approval was based on data from the Phase 3 POD1UM-303/InterAACT2 trial evaluating Zynyz in combination with platinum-based chemotherapy (carboplatin-paclitaxel) in adult patients with metastatic or inoperable

GBC AG Analyst Coverage Report on Mexedia S.p.A. Società Benefit Completed and Published22.12.2025 08:30:00 CET | Press release

Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) (“Mexedia” or the “Company”) informs that the analyst coverage report prepared by GBC AG – one of the leading independent financial research firms in Germany –, developed within an issuer-sponsored research framework, has been completed and is now publicly available. The report follows the re-initiation of analyst coverage by GBC AG previously communicated by the Company and is based exclusively on publicly available information. The content, assumptions and conclusions of the report are solely attributable to the analyst. The GBC AG analyst coverage report is available on the Company’s official website at the following address: https://mexedia.com/en/financial-statements-and-reports/ and on the analyst’s website. Daniel Gilcher, Chief Financial Officer of Mexedia S.p.A. Società Benefit, stated: “The completion and publication of the analyst coverage report by GBC AG represents the conclus

Hisense Joins HEVC Advance Patent Pool22.12.2025 03:06:00 CET | Press release

Access Advance LLC, the global leader in video codec patent pool licensing, today announced that Hisense Group Holdings Co., Ltd. has joined the HEVC Advance Patent Pool as a Licensee. Hisense joins the recent additions to the Access Advance patent pools, including Xiaomi, MSI, Transsion, and expanded relationships with Huawei, HP and Sharp. Hisense, headquartered in Qingdao, China, is one of the world's largest television manufacturers, with a global presence spanning Asia, Europe, the Americas, and beyond. The company's products reach consumers in more than 160 countries and regions worldwide. "We are pleased to welcome Hisense to the HEVC Advance Patent Pool," said Peter Moller, CEO of Access Advance. "This agreement is the result of extensive engagement between our teams over a considerable period of time. Hisense's decision to join the pool reflects a recognition that transparent, efficient licensing solutions benefit both innovators and implementers across the video technology ec

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye